Skip to Main Content

Paper Details

Effects of lifestyle interventions on epigenetic signatures of liver fat: Central randomized controlled trial.
Liver Int
12
2021
A2MP1, AC074286.1, CRACR2A, CpG, CpG site, CpGs, DNA, FARP1, FARP1 CpGs, FARP1 rs9584805, IHF, NAFLD, NAFLD related genes, PA, Single-nucleotide polymorphisms, candidate genes, carbohydrate, cg00071727, cg14335324, men, nonalcoholic fatty-liver disease, participants, rs9584805
Author NameAffiliation
Ilan ShelefSoroka University Medical Center
Peter F StadlerUniversity of Leipzig
Peter F StadlerCompetence Center for Scalable Data Services and Solutions Dresden/Leipzig, Leipzig Research Center for Civilization Diseases, University of Leipzig
Peter F StadlerMax Planck Institute for Mathematics in the Sciences
Peter F StadlerFraunhofer Institute for Cell Therapy and Immunology
Peter F StadlerUniversity of Vienna
Peter F StadlerCenter for RNA in Technology and Health, University of Copenhagen
Peter F StadlerSanta Fe Institute
Matthias BlüherHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich at the University of Leipzig and University Hospital Leipzig
Matthias BlüherUniversity of Leipzig Medical Center
Michael StumvollHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG) of the Helmholtz Center Munich at the University of Leipzig and University Hospital Leipzig
Michael StumvollUniversity of Leipzig Medical Center
Michael Stumvoll
Peter KovacsUniversity of Leipzig Medical Center
  • 1 - 14

Datasets